Mu-opioid and GABA(B) receptors modulate different types of Ca2+ currents in rat nodose ganglion neurons

Neuroscience. 1998 Aug;85(3):939-56. doi: 10.1016/s0306-4522(97)00674-x.

Abstract

Whole-cell patch-clamp recordings were obtained from nodose ganglion neurons acutely dissociated from 10-30-day-old rats to characterize the Ca2+ channel types that are modulated by GABA(B) and mu-opioid receptors. Five components of high-threshold current were distinguished on the basis of their sensitivity to blockade by omega-conotoxin GVIA, nifedipine, omega-agatoxin IVA and omega-conotoxin MVIIC. Administration of the mu-opioid agonist H-Tyr-D-Ala-Gly-Phe(N-Me)-Gly-ol (0.3-1 mM) or the GABA(B) agonist baclofen in saturating concentrations suppressed high-threshold Ca2+ currents by 49.9+/-2.4% (n=69) and 18.7+/-2.1% (n=35), respectively. The inhibition by H-Tyr-D-Ala-Gly-Phe(N-Me)-Gly-ol exceeded that by baclofen in virtually all neurons that responded to both agonists (67%), and occlusion experiments revealed that responses to mu-opioid and GABA(B) receptor activation were not linearly additive. In addition, administration of staurosporine, a non-selective inhibitor of protein kinase A and C, did not affect the inhibitory responses to either agonist or prevent the occlusion of baclofen-induced current inhibition by H-Tyr-D-Ala-Gly-Phe(N-Me)-Gly-ol. Blockade of N-type channels by omega-conotoxin GVIA eliminated current suppression by baclofen in all cells tested (n=11). Mu-opioid-induced inhibition in current was abolished by omega-conotoxin GVIA in 12 of 30 neurons tested, but was only partially reduced in the remaining 18 neurons. In the latter cells administration of omega-agatoxin IVA reduced, but did not eliminate the mu-opioid sensitive current component that persisted after blockade of N-type channels. This residual component of mu-opioid-sensitive current was blocked completely by omega-conotoxin MVIIC in nine neurons, whereas responses to H-Tyr-D-Ala-Gly-Phe(N-Me)-Gly-ol were still recorded in the remaining cells after administration of these Ca2+ channel toxins and nifedipine. Dihydropyridine-sensitive (L-type) current was not affected by activation of mu-opioid or GABA(B) receptors in any of the neurons. These data indicate that in nodose ganglion neurons mu-opioid receptors are negatively coupled to N-, P- and Q-type channels as well as to a fourth, unidentified toxin-resistant Ca2+ channel. In contrast, GABA(B) receptors are coupled only to N-type channels. Furthermore, the results do not support a role for either protein kinase C or A in the modulatory pathway(s) coupling mu-opioid and GABA(B) receptors to Ca2+ channels, but rather lend credence to the notion that the signalling mechanisms utilized by these two receptors might simply compete for inhibitory control of a common pool of N-type channels.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Analgesics, Opioid / pharmacology
  • Animals
  • Baclofen / analogs & derivatives
  • Baclofen / pharmacology
  • Cadmium / pharmacology
  • Calcium / metabolism*
  • Calcium Channel Agonists / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / physiology
  • Calcium Channels, L-Type
  • Calcium Channels, N-Type*
  • Dose-Response Relationship, Drug
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Enkephalins / pharmacology
  • GABA Agonists / pharmacology
  • GABA Antagonists / pharmacology
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Nerve Tissue Proteins / physiology
  • Neurons / chemistry
  • Neurons / metabolism*
  • Nifedipine / pharmacology
  • Nodose Ganglion / chemistry
  • Nodose Ganglion / cytology*
  • Nodose Ganglion / metabolism
  • Patch-Clamp Techniques
  • Peptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-B / physiology*
  • Receptors, Opioid, mu / agonists
  • Receptors, Opioid, mu / antagonists & inhibitors
  • Receptors, Opioid, mu / physiology*
  • Spider Venoms / pharmacology
  • omega-Agatoxin IVA
  • omega-Conotoxin GVIA
  • omega-Conotoxins*

Substances

  • Analgesics, Opioid
  • Calcium Channel Agonists
  • Calcium Channel Blockers
  • Calcium Channels
  • Calcium Channels, L-Type
  • Calcium Channels, N-Type
  • Enkephalins
  • GABA Agonists
  • GABA Antagonists
  • Narcotic Antagonists
  • Nerve Tissue Proteins
  • Peptides
  • Receptors, GABA-B
  • Receptors, Opioid, mu
  • Spider Venoms
  • omega-Agatoxin IVA
  • omega-Conotoxins
  • voltage-dependent calcium channel (P-Q type)
  • Cadmium
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • omega-conotoxin-MVIIC
  • Naloxone
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • omega-Conotoxin GVIA
  • Baclofen
  • Nifedipine
  • saclofen
  • Calcium